Novo Nordisk Unusual Options Activity For July 26
Novo Nordisk Unusual Options Activity For July 26
Investors with a lot of money to spend have taken a bearish stance on Novo Nordisk (NYSE:NVO).
有大量資金可以花的投資者對諾和諾德（紐約證券交易所代碼：NVO）採取了看跌立場。
And retail traders should know.
零售交易者應該知道。
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
今天，當交易出現在我們在本辛加追蹤的公開期權歷史記錄上時，我們注意到了這一點。
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with NVO, it often means somebody knows something is about to happen.
無論這些是機構還是僅僅是富人，我們都不知道。但是，當 NVO 發生這麼大的事情時，通常意味着有人知道某件事即將發生。
So how do we know what these investors just did?
那麼我們怎麼知道這些投資者剛才做了什麼？
Today, Benzinga's options scanner spotted 21 uncommon options trades for Novo Nordisk.
今天，Benzinga的期權掃描儀發現了Novo Nordisk的21筆不常見的期權交易。
This isn't normal.
這不正常。
The overall sentiment of these big-money traders is split between 42% bullish and 52%, bearish.
這些大資金交易者的整體情緒分爲42％的看漲和52％的看跌。
Out of all of the special options we uncovered, 13 are puts, for a total amount of $538,028, and 8 are calls, for a total amount of $425,198.
在我們發現的所有特殊期權中，有13種是看跌期權，總額爲538,028美元，8種是看漲期權，總額爲425,198美元。
Predicted Price Range
預測的價格區間
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $80.0 to $175.0 for Novo Nordisk over the last 3 months.
考慮到這些合約的交易量和未平倉合約，在過去的3個月中，鯨魚似乎一直將Novo Nordisk的價格定在80.0美元至175.0美元之間。
Insights into Volume & Open Interest
對交易量和未平倉合約的見解
In today's trading context, the average open interest for options of Novo Nordisk stands at 1150.07, with a total volume reaching 5,185.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Novo Nordisk, situated within the strike price corridor from $80.0 to $175.0, throughout the last 30 days.
在今天的交易背景下，諾和諾德期權的平均未平倉合約爲1150.07，總成交量達到5,185.00。隨附的圖表描繪了過去30天內Novo Nordisk高價值交易的看漲和看跌期權交易量以及未平倉合約的變化情況，行使價走勢從80.0美元到175.0美元不等。
Novo Nordisk Call and Put Volume: 30-Day Overview
Novo Nordisk 看漲和看跌交易量：30 天概述
Largest Options Trades Observed:
觀察到的最大期權交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NVO | CALL | SWEEP | BULLISH | 08/09/24 | $4.05 | $4.0 | $4.05 | $129.00 | $104.0K | 522505 | |
| NVO | CALL | SWEEP | BULLISH | 11/15/24 | $5.55 | $5.4 | $5.5 | $140.00 | $82.3K | 457152 | |
| NVO | PUT | SWEEP | BEARISH | 01/16/26 | $15.2 | $15.1 | $15.2 | $125.00 | $75.8K | 72455 | |
| NVO | PUT | SWEEP | BEARISH | 08/16/24 | $1.28 | $1.27 | $1.27 | $115.00 | $63.5K | 8422.0K | |
| NVO | CALL | SWEEP | BULLISH | 11/15/24 | $11.85 | $11.75 | $11.85 | $125.00 | $53.3K | 1245 |
| 符號 | 看跌/看漲 | 交易類型 | 情緒 | Exp。日期 | 問 | 出價 | 價格 | 行使價 | 總交易價格 | 未平倉合約 | 音量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NVO | 打電話 | 掃 | 看漲 | 08/09/24 | 4.05 美元 | 4.0 美元 | 4.05 美元 | 129.00 美元 | 104.0 萬美元 | 522505 | |
| NVO | 打電話 | 掃 | 看漲 | 11/15/24 | 5.55 美元 | 5.4 美元 | 5.5 美元 | 140.00 美元 | 82.3 萬美元 | 457152 | |
| NVO | 放 | 掃 | 粗魯的 | 01/16/26 | 15.2 美元 | 15.1 美元 | 15.2 美元 | 125.00 美元 | 75.8 萬美元 | 72455 | |
| NVO | 放 | 掃 | 粗魯的 | 08/16/24 | 1.28 美元 | 1.27 | 1.27 | 115.00 美元 | 63.5 萬美元 | 8422.0 K | |
| NVO | 打電話 | 掃 | 看漲 | 11/15/24 | 11.85 美元 | 11.75 美元 | 11.85 美元 | 125.00 美元 | 53.3 萬美元 | 1245 |
About Novo Nordisk
關於 Novo Nordisk
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
諾和諾德擁有全球品牌糖尿病治療市場約三分之一的份額，是全球領先的糖尿病護理產品提供商。該公司總部位於丹麥，生產和銷售各種人用和現代胰島素、注射型糖尿病治療藥物（如 GLP-1 療法）、口服抗糖尿病藥物和肥胖療法。Novo還有一個生物製藥板塊（約佔收入的10％），專門研究血友病和其他疾病的蛋白質療法。
Following our analysis of the options activities associated with Novo Nordisk, we pivot to a closer look at the company's own performance.
在分析了與Novo Nordisk相關的期權活動之後，我們將轉向仔細研究公司自身的表現。
Present Market Standing of Novo Nordisk
諾和諾德目前的市場地位
- Currently trading with a volume of 2,454,258, the NVO's price is down by -0.41%, now at $127.34.
- RSI readings suggest the stock is currently may be approaching oversold.
- Anticipated earnings release is in 12 days.
- NVO目前的交易量爲2,454,258美元，價格下跌了-0.41％，目前爲127.34美元。
- RSI讀數表明，該股目前可能已接近超賣。
- 預計業績將在12天后發佈。
Professional Analyst Ratings for Novo Nordisk
諾和諾德的專業分析師評級
1 market experts have recently issued ratings for this stock, with a consensus target price of $160.0.
1位市場專家最近發佈了該股的評級，共識目標價爲160.0美元。
- An analyst from Cantor Fitzgerald downgraded its action to Overweight with a price target of $160.
- 坎託·菲茨傑拉德的一位分析師將其評級下調至增持，目標股價爲160美元。
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
與僅交易股票相比，期權是一種風險更高的資產，但它們具有更高的獲利潛力。嚴肅的期權交易者通過每天自我教育、擴大交易規模、關注多個指標以及密切關注市場來管理這種風險。
譯文內容由第三人軟體翻譯。